Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ITF Therapeutics is the U.S.-based rare disease division of Italfarmaco S.p.A., a global pharmaceutical company with a legacy of innovation since 1938. Operating in over 90 countries, Italfarmaco has developed numerous therapeutic products addressing unmet medical needs. Launched in January 2024, ITF Therapeutics focuses on developing and commercializing treatments for rare diseases. Committed to collaboration, we partner with...
ITF Therapeutics is the U.S.-based rare disease division of Italfarmaco S.p.A., a global pharmaceutical company with a legacy of innovation since 1938. Operating in over 90 countries, Italfarmaco has developed numerous therapeutic products addressing unmet medical needs. Launched in January 2024, ITF Therapeutics focuses on developing and commercializing treatments for rare diseases. Committed to collaboration, we partner with patient advocacy and treatment communities to ensure our programs align with their needs, advancing impactful solutions for rare disease patients.

List your booth number for exhibitions, ask us